Acorah Software Products - Accounts Production16.4.675falsetruefalsetrueNo description of principal activity21 March 202431 March 202531 March 202515582674Mr ABDELRAHMAN MAHMOUD MOUSSAiso4217:GBPiso4217:EURiso4217:USDxbrli:sharesxbrli:purexbrli:pure155826742024-03-20155826742025-03-31155826742024-03-212025-03-3115582674frs-core:CurrentFinancialInstruments2025-03-3115582674frs-bus:PrivateLimitedCompanyLtd2024-03-212025-03-3115582674frs-bus:FilletedAccounts2024-03-212025-03-3115582674frs-bus:Micro-entities2024-03-212025-03-3115582674frs-bus:AuditExempt-NoAccountantsReport2024-03-212025-03-3115582674frs-bus:Director12024-03-212025-03-31
Registered number: 15582674
A&M PHARMA LTD
Unaudited Financial Statements
For the Period 21 March 2024 to 31 March 2025
UK TAX ACCOUNTANTS
2 Victor Street
Bradford
West Yorkshire
BD9 4RB
A&M PHARMA LTD
Balance Sheet
As At 31 March 2025
Balance Sheet
Registered number: 15582674
31 March 2025
£
Current assets
12,220
Creditors: Amounts Falling Due Within One Year
(10,243)
NET CURRENT ASSETS
1,977
TOTAL ASSETS LESS CURRENT LIABILITIES
1,977
Accruals and deferred income
(550)
NET ASSETS
1,427
CAPITAL AND RESERVES
1,427
Notes
1.General Information
A&M PHARMA LTD is a private company, limited by shares, incorporated in England & Wales, registered number 15582674. The registered office is 21 GAINSBOROUGH COURT, LONDON, W4 4BD.
2.Average Number of Employees
Average number of employees, including directors, during the period was: 1
1
For the period ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.